In part 2, Dr. Riordan discusses case studies of spinal cord injury patients treated with CD34+ and mesenchymal stem cells harvested from human umbilical cord wharton's jelly and cord blood, animal studies using mesenchymal stem cells, immunosuppression requirements in allogeneic stem cell treatments, intrathecal and intravenous administration of autologous bone marrow stem cells in spinal cord injury patients, and the role adult stem cell trophic factors in tissue regeneration.
Tuesday, May 22, 2012
Friday, May 18, 2012
Neil Riordan PhD - Stem Cell Therapy for Spinal Cord Injury (Video Part 1 of 5)
Part 1: The Stem Cell Institute's Founder, Dr. Neil Riordan discusses mesenchymal stem cells from umbilical cord Wharton's jelly, stem cell expansion, therapeutic potential of umbilical cord mesenchymal stem cells vs. bone marrow mesenchymal stem cells, CD34+ hematopoietic stem cells from umbilical cord blood and the scientific rationale supporting stem cell treatment of spinal cord injury.
Subscribe to:
Comments (Atom)